PublisherDOIYearVolumeIssuePageTitleAuthor(s)Link
Clinical and Molecular Hepatology10.3350/cmh.2013.19.4.3252013194325KASL clinical practice guidelines: Management of nonalcoholic fatty liver disease http://synapse.koreamed.org/pdf/10.3350/cmh.2013.19.4.325, http://synapse.koreamed.org/DOIx.php?id=10.3350/cmh.2013.19.4.325, http://www.e-cmh.org/upload/pdf/cmh-19-325.pdf
Clinical Liver Disease10.1002/cld.722201811481-81The diagnosis and management of nonalcoholic fatty liver disease: Practice guidance from the American Association for the Study of Liver Diseaseshttps://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1002%2Fcld.722, https://onlinelibrary.wiley.com/doi/full/10.1002/cld.722
Clinical and Molecular Hepatology10.3350/cmh.2013.19.3.2162013193216KASL Clinical Practice Guidelines: Management of Alcoholic Liver Disease http://synapse.koreamed.org/pdf/10.3350/cmh.2013.19.3.216, http://synapse.koreamed.org/DOIx.php?id=10.3350/cmh.2013.19.3.216, http://www.e-cmh.org/upload/pdf/cmh-19-216.pdf
Clinical Liver Disease10.1002/cld.66201214129-130Management of nonalcoholic fatty liver disease in childrenJean P. Mollestonhttps://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1002%2Fcld.66, http://onlinelibrary.wiley.com/wol1/doi/10.1002/cld.66/fullpdf
Clinical Liver Disease10.1002/cld.75201214125-128Pediatric nonalcoholic fatty liver disease: Prevalence, diagnosis, risk factors, and managementStavra A. Xanthakos, Rohit Kohlihttps://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1002%2Fcld.75, http://onlinelibrary.wiley.com/wol1/doi/10.1002/cld.75/fullpdf
Clinical Liver Disease10.1002/cld.12162022196222-226The diagnosis and management of nonalcoholic fatty liver disease: A patient‐friendly summary of the 2018 AASLD guidelinesConnor Griffin, Ranjeeta Bahirwanihttps://onlinelibrary.wiley.com/doi/pdf/10.1002/cld.1216, https://onlinelibrary.wiley.com/doi/full-xml/10.1002/cld.1216, https://onlinelibrary.wiley.com/doi/pdf/10.1002/cld.1216
Clinical and Molecular Hepatology10.3350/cmh.2014.20.2.89201420289KASL clinical practice guidelines: Management of Hepatitis C http://synapse.koreamed.org/pdf/10.3350/cmh.2014.20.2.89, http://synapse.koreamed.org/DOIx.php?id=10.3350/cmh.2014.20.2.89, http://www.e-cmh.org/upload/pdf/cmh-20-89.pdf
Clinical Liver Disease10.1002/cld.65201214104-107Nonalcoholic fatty liver disease: Indications for liver biopsy and noninvasive biomarkersMazen Noureddin, Rohit Loombahttps://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1002%2Fcld.65, http://onlinelibrary.wiley.com/wol1/doi/10.1002/cld.65/fullpdf
Clinical and Molecular Hepatology10.3350/cmh.2016.22.1.76201622176-139KASL clinical practice guidelines: management of hepatitis C http://e-cmh.org/upload/pdf/cmh-22-1-76.pdf, http://e-cmh.org/journal/view.php?doi=10.3350/cmh.2016.22.1.76, http://www.e-cmh.org/upload/pdf/cmh-22-1-76.pdf
Clinical Liver Disease10.1002/cld.27201214112-113Natural history of nonalcoholic fatty liver diseaseRohini Mehta, Zobair M. Younossihttps://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1002%2Fcld.27, http://onlinelibrary.wiley.com/wol1/doi/10.1002/cld.27/fullpdf